Prestige Consumer Healthcare Inc (PBH)
69.83
-0.30
(-0.43%)
USD |
NYSE |
Apr 25, 12:21
Prestige Consumer Healthcare Price to Book Value: 2.166 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.175 |
| April 23, 2024 | 2.209 |
| April 22, 2024 | 2.165 |
| April 19, 2024 | 2.161 |
| April 18, 2024 | 2.120 |
| April 17, 2024 | 2.110 |
| April 16, 2024 | 2.111 |
| April 15, 2024 | 2.114 |
| April 12, 2024 | 2.116 |
| April 11, 2024 | 2.146 |
| April 10, 2024 | 2.138 |
| April 09, 2024 | 2.146 |
| April 08, 2024 | 2.129 |
| April 05, 2024 | 2.145 |
| April 04, 2024 | 2.165 |
| April 03, 2024 | 2.154 |
| April 02, 2024 | 2.170 |
| April 01, 2024 | 2.224 |
| March 28, 2024 | 2.251 |
| March 27, 2024 | 2.253 |
| March 26, 2024 | 2.233 |
| March 25, 2024 | 2.221 |
| March 22, 2024 | 2.272 |
| March 21, 2024 | 2.292 |
| March 20, 2024 | 2.276 |
| Date | Value |
|---|---|
| March 19, 2024 | 2.282 |
| March 18, 2024 | 2.284 |
| March 15, 2024 | 2.316 |
| March 14, 2024 | 2.296 |
| March 13, 2024 | 2.329 |
| March 12, 2024 | 2.300 |
| March 11, 2024 | 2.313 |
| March 08, 2024 | 2.286 |
| March 07, 2024 | 2.252 |
| March 06, 2024 | 2.215 |
| March 05, 2024 | 2.210 |
| March 04, 2024 | 2.233 |
| March 01, 2024 | 2.175 |
| February 29, 2024 | 2.158 |
| February 28, 2024 | 2.158 |
| February 27, 2024 | 2.167 |
| February 26, 2024 | 2.171 |
| February 23, 2024 | 2.163 |
| February 22, 2024 | 2.153 |
| February 21, 2024 | 2.149 |
| February 20, 2024 | 2.133 |
| February 16, 2024 | 2.145 |
| February 15, 2024 | 2.134 |
| February 14, 2024 | 2.10 |
| February 13, 2024 | 2.065 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.282
Minimum
Mar 23 2020
2.329
Maximum
Mar 13 2024
1.775
Average
1.796
Median
Feb 03 2023
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.651 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6800 |
| Theriva Biologics Inc | 0.1648 |
| Oragenics Inc | 3.129 |
Price to Book Value Related Metrics
| PS Ratio | 3.081 |
| Price to Free Cash Flow | 15.06 |
| Price | 69.83 |
| Earnings Yield | -2.35% |
| Market Cap | 3.467B |
| Operating PE Ratio | 10.00 |